Aurobindo Pharma posts record quarterly revenue of Rs 10,263 crore as net profit jumps 32.5%

Strong growth across US, Europe and emerging markets drives 24% revenue surge

Lupin Q2 profit plunges 22.2% despite 14% revenue growth

The company reported sales of Rs 7,785.5 crore for Q2 FY27

Zydus Lifesciences Q2 revenue jumps 29% to Rs 7,910 crore but net profit falls 27%

Biocon Q2 profit at Rs 41 crore as revenue rises 2%, biopharma biz grows 5%

Merck to sell CDMO biz to Lonza in mid-triple-digit million-Euro deal

The move will give Merck a more concentrated Life Science portfolio

Bayer raises 2026 outlook as pharma growth accelerates

While Pharmaceuticals gathered momentum, Crop Science and Consumer Health continued to perform in line with their respective targets despite challenging market conditions

Pfizer posts strong Q3 results raising 2026 forecast as new products drive growth

A major growth driver was Pfizer's launched and acquired product portfolio, which recorded a striking 32% year-over-year operational revenue increase.

Cambrex pumps $120 million into Iowa facility to boosts drug manufacturing capacity by 25%

The project will add 160,000 litres of manufacturing capacity, increasing the facility's total capacity by approximately 25% to nearly one million litres

Akums posts 168% jump in Q2 profit as revenue surges 32% & EBITDA more than doubles

Akums has expanded beyond pharmaceutical manufacturing by acquiring Oriflame India's manufacturing business for Rs 56 crore

Thyrocare enters pregnancy testing market as it launches India’s first home kit

The diagnostics major has also roped in actor Yami Gautam Dhar as the brand ambassador for the new product

Adalvo acquires Enzene’s romiplostim biosimilar programme to strengthens global biosimilars push

Deal marks a strategic shift for Enzene towards a focused global CDMO business

Major TRANSFORM II trial finds sirolimus-coated balloon matches drug-eluting stents in coronary artery disease

One of the key findings was the low rate of bailout stenting in the SCB group

Wockhardt Q2 revenue jumps 24% to Rs 969 crore; H1 growth hits 25%

EBITDA for Q2 FY27 stood at Rs 165 crore, marginally higher than Rs 160 crore in Q2 FY26

Teva pulls plug on Phase 2 trial of experimental MSA drug post futility analysis

Emrusolmin is designed to target alpha-synuclein aggregation, a key disease mechanism believed to contribute to MSA

Granules India reports 39% surge in Q2 FY27 PAT to Rs. 182 Cr

Operational revenue grew 20.3% YoY to a record Rs. 1,560 crore

Zydus Wellness consolidated net sales up by 74.6% in Q2 FY27

Nutralite achieved robust, double-digit growth across its portfolio

Shilpa CDMO to invest $50 million in commercial peptide manufacturing

First commercial line comes online in December 2026 as CDMO scales capacity for GLP-1s and next-generation complex peptides

Sun Pharma Q2 net profit jumps to Rs 3,162 Cr; revenue rises 11.8% to Rs 16,100 Cr

Sun Pharma invested Rs 778.4 crore in research and development during the quarter, equivalent to 4.8% of sales

Spektus Pharma and GEBRO strike global deal to commercialise twice-daily pain drug ActraFlex

Under the agreement, the companies will divide global commercialisation responsibilities across key international markets

Scottish Secretary visits Agilus Diagnostics’ Mumbai lab to explores India collaboration on Rapid Microbial Testing